Mylonakis, A.; Kozadinos, A.; Frountzas, M.; Kapetanakis, E.I.; Lidoriki, I.; Despotidis, M.; Karanikki, E.; Triantafyllou, T.; Theodorou, D.; Toutouzas, K.G.;
et al. The Role of Visfatin in Gastric and Esophageal Cancer: From Biomarker to Therapeutic Target. Cancers 2025, 17, 1377.
https://doi.org/10.3390/cancers17081377
AMA Style
Mylonakis A, Kozadinos A, Frountzas M, Kapetanakis EI, Lidoriki I, Despotidis M, Karanikki E, Triantafyllou T, Theodorou D, Toutouzas KG,
et al. The Role of Visfatin in Gastric and Esophageal Cancer: From Biomarker to Therapeutic Target. Cancers. 2025; 17(8):1377.
https://doi.org/10.3390/cancers17081377
Chicago/Turabian Style
Mylonakis, Adam, Alexandros Kozadinos, Maximos Frountzas, Emmanouil I. Kapetanakis, Irene Lidoriki, Markos Despotidis, Eva Karanikki, Tania Triantafyllou, Dimitrios Theodorou, Konstantinos G. Toutouzas,
and et al. 2025. "The Role of Visfatin in Gastric and Esophageal Cancer: From Biomarker to Therapeutic Target" Cancers 17, no. 8: 1377.
https://doi.org/10.3390/cancers17081377
APA Style
Mylonakis, A., Kozadinos, A., Frountzas, M., Kapetanakis, E. I., Lidoriki, I., Despotidis, M., Karanikki, E., Triantafyllou, T., Theodorou, D., Toutouzas, K. G., & Schizas, D.
(2025). The Role of Visfatin in Gastric and Esophageal Cancer: From Biomarker to Therapeutic Target. Cancers, 17(8), 1377.
https://doi.org/10.3390/cancers17081377
